Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
* Required Fields
Pay by invoice
This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as those of the pharmaceutical sponsors. The study segments the market by product (drug substance and drug product), cell line (mammalian, microbial, and viral vectors and other modalities) and service (clinical and commercial) types. The market forecasts in this report are for 2020–2026. They capture key market developments, such as capacity expansions, mergers, acquisitions, and expanding services offerings set to impact the overall bio-CDMO market growth.Other discussions on the global bio-CDMO market include:• Impact of strategic imperatives on the industry• Growth drivers and restraints • Comprehensive insights on its competitive landscape • Revenue share estimates of top market participants• A strategic analysis of market developments regarding services offerings and business models • Growth opportunities centered on single-use technology in the development and manufacturing of personalized medicine, COVID-19 vaccine scale-up partnerships, assets co-development with small and midsize pharma companies, and opportunities in China’s domestic biopharma marketAuthor: Deepak Jayakumar
US and EU Biotech Industry VC Investment Growth Opportunities
Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market
US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Emerging Microbiome Technologies for Applications in Skin Care
Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024
consumer drone market
solar panel market
solar cell market
smart lighting market
artificial lift market
functional beverage market
3d printer market share
composite materials market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.